These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24269)

  • 1. Adrenergic stimulants and asthma mortality.
    Svedmyr N
    Scand J Respir Dis Suppl; 1977; 101():85-9. PubMed ID: 24269
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to beta-adrenoceptor stimulants.
    Br Med J; 1972 Jan; 1(5793):127-8. PubMed ID: 4400056
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired resistance to beta stimulants: a possible explantion for the rise in the asthma death rate in Britain.
    Conolly ME; George CF; Davies DS; Dollery CT
    Chest; 1973 Apr; 63():Suppl:16S-18S. PubMed ID: 4144441
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissociation of tracheobronchial and cardiac effects of some beta-adrenergic stimulants.
    Hinds L; Katz RL
    Anesthesiology; 1971 May; 34(5):445-9. PubMed ID: 4396619
    [No Abstract]   [Full Text] [Related]  

  • 5. [beta-adrenergic drugs on the treatment of bronchial asthma. Use and dangers (author's translation)].
    Harvengt C
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):190-9. PubMed ID: 1016526
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to beta-adrenoceptor stimulants and death from bronchial asthma.
    Blackwell EW; Conolly ME; Davies DS; Dollery CT; George CF
    Br J Pharmacol; 1971 Feb; 41(2):410P. PubMed ID: 4396706
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration.
    Larsson S
    Acta Med Scand Suppl; 1977; 608():1-40. PubMed ID: 20739
    [No Abstract]   [Full Text] [Related]  

  • 8. beta-Adrenergic bronchodilators and sudden death in asthmatics.
    Drug Ther Bull; 1976 Mar; 14(6):21-2. PubMed ID: 6237
    [No Abstract]   [Full Text] [Related]  

  • 9. [beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League].
    Gillissen A; Berdel D; Buhl R; Crieé CP; Kardos P; Magnussen H; Rabe KF; Rolke M; Vogelmeier C; Worth H; Virchow JC
    Dtsch Med Wochenschr; 2007 Jan; 132(1-2):33-9. PubMed ID: 17187322
    [No Abstract]   [Full Text] [Related]  

  • 10. Infrequent cardiac deaths occur in bronchial asthma.
    Ziment I
    Chest; 1992 Jun; 101(6):1703-5. PubMed ID: 1350973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy resistant asthma. Can beta-stimulants have an unfortunate long term effect?].
    Naess K
    Tidsskr Nor Laegeforen; 1972 Jun; 92(16):1132. PubMed ID: 4402579
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between methyl xanthines and beta adrenergic agonists.
    FDA Drug Bull; 1981 Nov; 11(3):19-20. PubMed ID: 6119269
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).
    Conolly ME; Davies DS; Dollery CT; George CF
    Br J Pharmacol; 1971 Oct; 43(2):389-402. PubMed ID: 4400573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aerosol therapy with sympathomimetics and mortality in bronchial asthma].
    Ovreberg K
    Tidsskr Nor Laegeforen; 1968 Oct; 88(19):1738-40. PubMed ID: 5700511
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta agonists and asthma mortality: déjà vu.
    Pearce N; Crane J; Burgess C; Jackson R; Beasley R
    Clin Exp Allergy; 1991 Jul; 21(4):401-10. PubMed ID: 1680532
    [No Abstract]   [Full Text] [Related]  

  • 16. Limited additional release of cardiac troponin I and T in isoproterenol-treated beagle dogs with cardiac injury.
    Feng X; Taggart P; Hall L; Bryant S; Sansone J; Kemmerer M; Herlich J; Lord P
    Clin Chem; 2005 Jul; 51(7):1305-7. PubMed ID: 15976123
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta adrenoceptor antagonists and respiratory disease.
    Tattersfield AE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S35-9. PubMed ID: 2427850
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacology of beta-receptor-blocking drugs.
    Dollery CT; Paterson JW; Conolly ME
    Clin Pharmacol Ther; 1969; 10(6):765-99. PubMed ID: 4393717
    [No Abstract]   [Full Text] [Related]  

  • 19. (+/-) isoprenaline revisited: adverse effects of sympathomimetics in asthma.
    Hansel TT; Schwarz F; Villiger B; Morley J
    Agents Actions Suppl; 1993; 43():271-80. PubMed ID: 8368168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.
    Dollery CT; Paterson JW; Conolly ME
    Clin Pharmacol Ther; 1969; 10(6):765-99. PubMed ID: 4390767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.